BG108369A - Производни на имидазо[1,5-а] пиримидо[5,4-d] бензазепин като gaba а рецепторни модулатори - Google Patents

Производни на имидазо[1,5-а] пиримидо[5,4-d] бензазепин като gaba а рецепторни модулатори Download PDF

Info

Publication number
BG108369A
BG108369A BG108369A BG10836903A BG108369A BG 108369 A BG108369 A BG 108369A BG 108369 A BG108369 A BG 108369A BG 10836903 A BG10836903 A BG 10836903A BG 108369 A BG108369 A BG 108369A
Authority
BG
Bulgaria
Prior art keywords
benzazepine
compound
formula
pyrimido
ethyl ester
Prior art date
Application number
BG108369A
Other languages
Bulgarian (bg)
English (en)
Inventor
Raffaello Masciardi
Andrew Thomas
Juergen Wichmann
Original Assignee
F.Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann - La Roche Ag filed Critical F.Hoffmann - La Roche Ag
Publication of BG108369A publication Critical patent/BG108369A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BG108369A 2001-05-18 2003-11-18 Производни на имидазо[1,5-а] пиримидо[5,4-d] бензазепин като gaba а рецепторни модулатори BG108369A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18

Publications (1)

Publication Number Publication Date
BG108369A true BG108369A (bg) 2005-01-31

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108369A BG108369A (bg) 2001-05-18 2003-11-18 Производни на имидазо[1,5-а] пиримидо[5,4-d] бензазепин като gaba а рецепторни модулатори

Country Status (38)

Country Link
US (1) US6686352B2 (zh)
EP (1) EP1399448B1 (zh)
JP (1) JP4068466B2 (zh)
KR (1) KR100533406B1 (zh)
CN (1) CN1230436C (zh)
AR (1) AR033753A1 (zh)
AT (1) ATE283857T1 (zh)
AU (1) AU2002338898B2 (zh)
BG (1) BG108369A (zh)
BR (1) BR0209859A (zh)
CA (1) CA2446903C (zh)
CZ (1) CZ20033355A3 (zh)
DE (1) DE60202147T2 (zh)
DK (1) DK1399448T3 (zh)
EC (1) ECSP034851A (zh)
ES (1) ES2232778T3 (zh)
GT (1) GT200200087A (zh)
HK (1) HK1066544A1 (zh)
HR (1) HRP20030890A2 (zh)
HU (1) HUP0400743A3 (zh)
IL (2) IL158572A0 (zh)
JO (1) JO2297B1 (zh)
MA (1) MA27024A1 (zh)
MX (1) MXPA03010529A (zh)
MY (1) MY127570A (zh)
NO (1) NO20035104D0 (zh)
NZ (1) NZ529097A (zh)
PA (1) PA8545201A1 (zh)
PE (1) PE20030041A1 (zh)
PL (1) PL366846A1 (zh)
PT (1) PT1399448E (zh)
RU (1) RU2287531C2 (zh)
SI (1) SI1399448T1 (zh)
SK (1) SK15252003A3 (zh)
TW (1) TWI251489B (zh)
WO (1) WO2002094834A1 (zh)
YU (1) YU90003A (zh)
ZA (1) ZA200308544B (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1771450T5 (da) 2004-05-14 2012-01-09 Millennium Pharm Inc Forbindelser og fremgangsmåder til inhibering af mitotisk progression ved inhibering af AURORA-kinase
CA2582235A1 (en) * 2004-10-04 2006-04-20 Millennium Pharmaceuticals, Inc. Lactam compounds useful as protein kinase inhibitors
KR100923399B1 (ko) * 2004-10-20 2009-10-23 에프. 호프만-라 로슈 아게 이미다조-벤조다이아제핀 유도체
WO2006045429A1 (en) * 2004-10-20 2006-05-04 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
ATE477255T1 (de) * 2005-10-11 2010-08-15 Hoffmann La Roche Imidazobenzdiazepinderivate
PE20080145A1 (es) 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CL2008003749A1 (es) 2007-12-17 2010-01-15 Janssen Pharmaceutica Nv Compuestos derivados de imidazol, oxazol, y tiazol pirimidina, moduladores de trpv1, proceso de preparacion, composicion farmaceutica y su uso en el tratamiento de enfermedades, trastornos o condicion de dolor, prurito, artritis, tos, asma, trastorno del oido interno y enfermedad inflamatoria intestinal, entre otras.
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
WO2010065134A1 (en) * 2008-12-05 2010-06-10 Millennium Pharmaceuticals, Inc. 5, 7-dihydro- 6h-pyrimido [ 5, 4-d] [ 1 ] benzazepin-6-thiones as plk inhibitors
KR101741168B1 (ko) 2008-12-22 2017-05-29 밀레니엄 파머슈티컬스 인코퍼레이티드 오로라 키나아제 억제제 및 항­cd 항체의 병용
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
BR112012020557A8 (pt) 2010-02-19 2018-01-02 Millennium Pharm Inc formas cristalinas de 4-{[9-cloro-7-(2-flúor-6-metoifenil)-5h-pirimido[5,4-d][2]benzazepin-2-il]amino}-2-metoxibenzoato de sódio
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
WO2014153509A1 (en) 2013-03-22 2014-09-25 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
MX2016007808A (es) 2013-12-20 2016-09-07 Agenebio Inc Derivados de benzodiazepina, composiciones, y metodos para tratar el deterioro congnitivo.
MX2020013374A (es) 2015-06-19 2022-05-06 Agenebio Inc Derivados de benzodiazepina, composiciones y metodos para tratar deterioro cognitivo.
WO2017015316A1 (en) 2015-07-21 2017-01-26 Millennium Pharmaceuticals, Inc. Administration of aurora kinase inhibitor and chemotherapeutic agents
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112020026062B1 (pt) 2018-06-19 2023-04-04 Agenebio, Inc Compostos derivados de benzodiazepina ou um sal farmaceuticamente aceitavel, isômero ou combinação dos mesmos, composição farmacêutica compreendendo os mesmos e usos dos mesmos para o tratamento de comprometimento cognitivo, câncer cerebral e psicose da doença de parkinson
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201311B (zh) 1991-06-17 1993-03-01 Hoffmann La Roche
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
CN1390217A (zh) 1999-11-12 2003-01-08 神经原公司 二环和三环杂芳族化合物
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
GT200200087A (es) 2003-06-19
PE20030041A1 (es) 2003-02-07
JP2004531563A (ja) 2004-10-14
AR033753A1 (es) 2004-01-07
CN1509289A (zh) 2004-06-30
MY127570A (en) 2006-12-29
US20030055042A1 (en) 2003-03-20
ECSP034851A (es) 2003-12-24
CA2446903A1 (en) 2002-11-28
EP1399448B1 (en) 2004-12-01
ZA200308544B (en) 2005-01-31
KR100533406B1 (ko) 2005-12-02
RU2003136078A (ru) 2005-05-27
AU2002338898B2 (en) 2007-03-15
IL158572A0 (en) 2004-05-12
HUP0400743A2 (hu) 2004-07-28
JO2297B1 (en) 2005-09-12
NO20035104L (no) 2003-11-17
PA8545201A1 (es) 2003-02-28
CZ20033355A3 (en) 2004-07-14
SK15252003A3 (sk) 2004-08-03
BR0209859A (pt) 2004-06-15
SI1399448T1 (en) 2005-02-28
DE60202147T2 (de) 2005-12-01
EP1399448A1 (en) 2004-03-24
DK1399448T3 (da) 2005-04-11
MA27024A1 (fr) 2004-12-20
IL158572A (en) 2010-02-17
JP4068466B2 (ja) 2008-03-26
HK1066544A1 (en) 2005-03-24
NO20035104D0 (no) 2003-11-17
CN1230436C (zh) 2005-12-07
HUP0400743A3 (en) 2007-09-28
ES2232778T3 (es) 2005-06-01
PT1399448E (pt) 2005-03-31
WO2002094834A1 (en) 2002-11-28
RU2287531C2 (ru) 2006-11-20
US6686352B2 (en) 2004-02-03
KR20040002975A (ko) 2004-01-07
YU90003A (sh) 2006-08-17
HRP20030890A2 (en) 2005-08-31
MXPA03010529A (es) 2004-03-02
NZ529097A (en) 2005-04-29
ATE283857T1 (de) 2004-12-15
AU2002338898B8 (en) 2002-12-03
CA2446903C (en) 2008-12-30
TWI251489B (en) 2006-03-21
PL366846A1 (en) 2005-02-07
DE60202147D1 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
BG108369A (bg) Производни на имидазо[1,5-а] пиримидо[5,4-d] бензазепин като gaba а рецепторни модулатори
DE60103776T2 (de) Benzodiazepinderivate als gaba-a-rezeptormodulatoren
AU2002338898A1 (en) Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as GABA A receptor modulators
RU2139873C1 (ru) Имидазодиазепины, способ их получения и лекарственное средство
AU2002217007A1 (en) Benzodiazepine derivatives as GABA A receptor modulators
CA2069382A1 (en) Imidazodiazepine
JP2008517010A (ja) ハロゲン置換ベンゾジアゼピン誘導体
RU2107686C1 (ru) Производное 3-оксадиазолил-5,6,7,8-тетрагидро-1,6-нафтиридина и производное 5,6,7,8-тетрагидро-1,6-нафтиридина
JP3390453B2 (ja) 5−置換−3−オキサジアゾリル−1,6−ナフチリジン−2(1h)−オン誘導体
JPH11279176A (ja) 1,2,4−オキサジアゾリルキノロン誘導体